scispace - formally typeset
L

Lucas Otaño

Researcher at Hospital Italiano de Buenos Aires

Publications -  56
Citations -  973

Lucas Otaño is an academic researcher from Hospital Italiano de Buenos Aires. The author has contributed to research in topics: Pregnancy & Prenatal diagnosis. The author has an hindex of 14, co-authored 50 publications receiving 814 citations.

Papers
More filters
Journal ArticleDOI

The effect of timing of cord clamping on neonatal venous hematocrit values and clinical outcome at term : A randomized, controlled trial

TL;DR: Delayed cord clamping at birth increases neonatal mean venous hematocrit within a physiologic range and seems to reduce the rate of neonatal anemia, and should be implemented to increase neonatal iron storage at birth.
Journal ArticleDOI

International Fetal Cardiac Intervention Registry: A Worldwide Collaborative Description and Preliminary Outcomes

TL;DR: Post-natal data from the IFCIR is presented to suggest potential benefit to fetal therapy among pregnancies considered for possible intervention and support proposals for additional work.
Journal ArticleDOI

Association between first trimester absence of fetal nasal bone on ultrasound and Down syndrome

TL;DR: To evaluate the association between absence of nasal bone on ultrasound and Down syndrome in fetuses at 11–14 weeks of pregnancy, a large number of patients with Down syndrome were diagnosed with the disease during pregnancy.
Journal ArticleDOI

Congenital dacryocystocele: prenatal 2- and 3-dimensional sonographic findings.

TL;DR: The purpose of this series is to present the experience with cases of dacryocystocele diagnosed prenatally, and the role of prenatal 3‐dimensional sonography, as an adjunct to 2‐dimensionalSonography, in the prenatal assessment of these cases is emphasized.
Journal ArticleDOI

Prenatal diagnosis of skeletal dysplasias: contribution of three-dimensional computed tomography.

TL;DR: 3D-CT may have a complementary role to US where fetal SD is suspected, but no specific diagnosis can be made using US alone, and further studies on clinical performance and risk-benefit analysis are needed.